Stay updated on Aducanumab for Early Alzheimer's: Clinical Trial
Sign up to get notified when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.

Latest updates to the Aducanumab for Early Alzheimer's: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference2%

- Check26 days agoChange DetectedUpdated page now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while retaining an earlier Revision: v3.0.2. This indicates a restructuring/revision of content with emphasis on versioning rather than new core information.SummaryDifference0.3%

- Check41 days agoChange DetectedUpdate: Revision changed from v3.0.1 to v3.0.2; the Back to Top element was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check55 days agoChange DetectedThe webpage has undergone significant updates, including the addition of numerous facility names and locations across various countries, particularly in Europe and Japan, as well as new MedlinePlus related topics concerning Alzheimer's disease. Additionally, several previous entries have been removed, indicating a shift in focus or content structure.SummaryDifference13%

- Check69 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Aducanumab for Early Alzheimer's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.